Chemical Name: 5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime
Biological ActivityPotent B-Raf inhibitor (Kd = 0.3 nM). Selective for B-Raf against 46 other kinases (Ki app values are 0.16 and 1.72 nM for B-Raf and c-Raf respectively). Decreases anchorage-independent growth of melanoma cell lines. Inhibits ERK phosphorylation and proliferation in tumor cells expressing B-RafV600E.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885.
King et al.
Cancer Res., 2006;66:11100
The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.
Takle et al.
Citations for SB 590885
The citations listed below are publications that use Tocris products. Selected citations for SB 590885 include:
3 Citations: Showing 1 - 3
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Authors: Najm Et al.
PLoS One 2015;522:216
Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase domain.
Authors: Wagenaar Et al.
Pigment Cell Melanoma Res 2014;27:124
A modified HSP70 inhibitor shows broad activity as an anticancer agent.
Authors: Balaburski Et al.
Mol Cancer Res 2013;11:219
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for SB 590885
There are currently no reviews for this product. Be the first to review SB 590885 and earn rewards!
Have you used SB 590885?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image